(LZM) Lifezone Metals - Overview
Sector: Basic Materials | Industry: Other Industrial Metals & Mining | Exchange: NYSE (USA) | Market Cap: 464m USD | Total Return: 61.1% in 12m
Avg Turnover: 3.37M
Warnings
Interest Coverage Ratio -5.7 is critical
Beneish M-Score 1.00 > -1.5 - likely earnings manipulation
Altman Z'' -14.45 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Lifezone Metals Limited (NYSE: LZM) is a metals production and intellectual property company headquartered in the Isle of Man. Its primary focus is the development of the Kabanga Nickel Project in Tanzania, which aims to provide low-carbon nickel, copper, and cobalt for the global battery supply chain. The company operates within the Diversified Metals & Mining sector, utilizing its proprietary hydrometallurgical technology as a cleaner alternative to traditional smelting processes.
The business model combines resource extraction with intellectual property licensing, targeting the increasing demand for sustainably sourced transition metals. Investors may find it useful to examine ValueRay for deeper analysis of the companys valuation and market position. This hybrid approach allows the company to potentially generate revenue from both physical commodity sales and the licensing of its green processing technology to third-party mining operators.
- Kabanga Nickel Project development milestones dictate long-term valuation and capital requirements
- Hydromet technology licensing agreements provide high-margin intellectual property revenue streams
- Nickel price volatility directly impacts projected cash flows and project NPV
- Strategic partnerships with BHP and Glencore influence project funding and execution
- Tanzanian regulatory environment and mining policy changes affect operational stability
| Net Income: -84.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.50 > 0.02 and ΔFCF/TA 2.78 > 1.0 |
| NWC/Revenue: -2.97k% < 20% (prev -2.20k%; Δ -777.3% < -1%) |
| CFO/TA -0.18 > 3% & CFO -32.0m > Net Income -84.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (83.8m) vs 12m ago 5.99% < -2% |
| Gross Margin: -51.31% > 18% (prev 0.26%; Δ -5.16k% > 0.5%) |
| Asset Turnover: 0.75% > 50% (prev 0.71%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: -5.69 > 6 (EBITDA TTM -76.9m / Interest Expense TTM 13.9m) |
| A: -0.21 (Total Current Assets 22.2m - Total Current Liabilities 59.1m) / Total Assets 175.8m |
| B: -2.66 (Retained Earnings -468.1m / Total Assets 175.8m) |
| C: -0.48 (EBIT TTM -79.3m / Avg Total Assets 166.2m) |
| D: -1.13 (Book Value of Equity -116.4m / Total Liabilities 102.9m) |
| Altman-Z'' = -14.45 = D |
| DSRI: 1.06 (Receivables 1.10m/933k, Revenue 1.24m/1.11m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 147.3 (AQ_t 0.84 / AQ_t-1 0.01) |
| SGI: 1.12 (Revenue 1.24m / 1.11m) |
| TATA: -0.30 (NI -84.8m - CFO -32.0m) / TA 175.8m) |
| Beneish M = 83.57 (Cap -4..+1) = D |
As of May 26, 2026, the stock is trading at USD 5.09 with a total of 530,000 shares traded.
Over the past week, the price has changed by +4.09%,
over one month by +3.04%,
over three months by +21.19% and
over the past year by +61.08%.
Lifezone Metals has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy LZM.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 8.6 | 69.5% |
P/S = 439.202
P/B = 6.288
Revenue TTM = 1.24m USD
EBIT TTM = -79.3m USD
EBITDA TTM = -76.9m USD
Long Term Debt = 16.7m USD (from longTermDebt, last quarter)
Short Term Debt = 40.6m USD (from shortTermDebt, last quarter)
Debt = 60.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 2.05m
Net Debt = 40.3m USD (calculated: Debt 60.5m - CCE 20.1m)
Enterprise Value = 504.6m USD (464.3m + Debt 60.5m - CCE 20.1m)
Interest Coverage Ratio = -5.69 (Ebit TTM -79.3m / Interest Expense TTM 13.9m)
EV/FCF = -5.72x (Enterprise Value 504.6m / FCF TTM -88.3m)
FCF Yield = -17.49% (FCF TTM -88.3m / Enterprise Value 504.6m)
FCF Margin = -7.12k% (FCF TTM -88.3m / Revenue TTM 1.24m)
Net Margin = -6.85k% (Net Income TTM -84.8m / Revenue TTM 1.24m)
Gross Margin = -51.31% ((Revenue TTM 1.24m - Cost of Revenue TTM 1.87m) / Revenue TTM)
Gross Margin QoQ = -57.43% (prev -76.21%)
Tobins Q-Ratio = 2.87 (Enterprise Value 504.6m / Total Assets 175.8m)
Interest Expense / Debt = 23.05% (Interest Expense 13.9m / Debt 60.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -62.6m (EBIT -79.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.38 (Total Current Assets 22.2m / Total Current Liabilities 59.1m)
Debt / Equity = 0.82 (Debt 60.5m / totalStockholderEquity, last quarter 73.8m)
Debt / EBITDA = -0.52 (negative EBITDA) (Net Debt 40.3m / EBITDA -76.9m)
Debt / FCF = -0.46 (negative FCF - burning cash) (Net Debt 40.3m / FCF TTM -88.3m)
Total Stockholder Equity = 86.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -51.05% (Net Income -84.8m / Total Assets 175.8m)
RoE = -15.30% (Net Income TTM -84.8m / Total Stockholder Equity 554.6m)
RoCE = -13.88% (EBIT -79.3m / Capital Employed (Equity 554.6m + L.T.Debt 16.7m))
RoIC = -45.68% (negative operating profit) (NOPAT -62.6m / Invested Capital 137.1m)
WACC = 15.78% (E(464.3m)/V(524.7m) * Re(15.46%) + D(60.5m)/V(524.7m) * Rd(23.05%) * (1-Tc(0.21)))
Discount Rate = 15.46% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 62.86 | Cagr: 45.86%
[DCF] Fair Price = unknown (Cash Flow -88.3m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.07 | # QB: 0
Revenue Correlation: -80.95 | Revenue CAGR: -59.59% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.06 | Chg30d=-20.00% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=-0.25 | Chg30d=-31.58% | Revisions=-20% | GrowthEPS=+26.8% | GrowthRev=+153.5%
EPS next Year (2027-12-31): EPS=-0.39 | Chg30d=N/A | Revisions=-20% | GrowthEPS=-56.0% | GrowthRev=+37.5%